Calcium Folinate Injection 100?mg
$2.00
Calcium Folinate Injection (Leucovorin) is a tetrahydrofolate derivative manufactured by Guoyao Yixin Pharmaceutical (NMPA No.?H20053382; Code?86903458000403). Supplied as 100?mg per vial ×?5 vials/box. Primarily used as an antidote for folate–antagonist toxicity (e.g., methotrexate rescue) and chemosensitizer in combination with pyrimidine analogs in research models. Strictly for laboratory research?Please consult the staff for other purposes?
描述
Calcium Folinate Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Calcium Folinate Injection (Leucovorin) |
| Strength | 100?mg per vial |
| Quantity | 5 vials per box |
| Dosage Form | Sterile powder for injection |
| Approval No. (NMPA) | H20053382 |
| Product Code | 86903458000403 |
| Manufacturer | Guoyao Yixin Pharmaceutical Co., Ltd |
| CAS Number | 56?88?4 (folinic acid) |
| Molecular Formula | C??H??CaN?O?·5H?O; ~601.6?g/mol |
| Intended Use | Laboratory research only — not for clinical or veterinary use |
Mechanism of Action
Calcium Folinate is an active tetrahydrofolate analogue that bypasses dihydrofolate reductase inhibition, replenishing nucleic?acid precursor pools to rescue normal cells after antifolate exposure. It also enhances fluoropyrimidine cytotoxicity by stabilizing thymidylate synthase complexes.
Research & Pharmacology Context
-
Folate antagonist rescue: Standard antidote after high-dose methotrexate or pyrimidine analog therapy in preclinical models.
dailymed.nlm.nih.gov+9anmfonline.org+9pdf.hres.ca+9 -
Chemotherapy enhancement: Used in conjunction with 5?fluorouracil in colorectal cancer models to improve efficacy.
-
Clinical & pharmacokinetic data: Widely used injectable form; over 90% renal excretion, clinical dosing from adult chemotherapy protocols.
? Research Applications
-
Antidote profiling in high-dose methotrexate toxicity models
-
Synergy studies with fluoropyrimidines in colorectal cancer cell lines or xenografts
-
Folate metabolism and nucleotide synthesis pathway research
-
Pharmacokinetic/pharmacodynamic modeling in preclinical studies
?? Research?Use Only Disclaimer
This product is provided strictly for laboratory research and development use only. Not intended for clinical, diagnostic, therapeutic, or veterinary applications.
其他信息
| 重量 | 1.1 公斤 |
|---|---|
| 尺寸 | 18 × 16 × 18 厘米 |
相关产品
-
Regorafenib Tablets (Reodixin®) – 40?mg
Regorafenib (Reodixin®) is an oral multi-kinase inhibitor targeting angiogenesis, proliferation, metastasis, and tumor immunity. FDA-approved for several advanced solid tumors. Here offered as 40?mg tablets in a 28-count bottle—strictly for laboratory research use only $1.00 -
Lparomlimab & Tuvonralimab Injection (Qibeian) – 50?mg/2?mL Vial Price comparison
Lparomlimab & Tuvonralimab Injection Qibeian is a bi-functional monoclonal antibody combination (PD?1/CTLA?4) developed by Qilu Pharmaceutical (QL1706), supplied as 50?mg in 2?mL vials. Approved by China’s NMPA (conditional marketing authorization No. S20240044; drug code 86904021005238). Intended exclusively for lab and investigative research applications, not for clinical or human use. $1.00 -
Pirtobrutinib Tablets (Jaypirca) – 100?mg × 14 Tablets × 4 Blisters Price comparison
Pirtobrutinib Tablets (brand name: Jaypirca) is the world’s first non-covalent BTK inhibitor, provided here as 100?mg oral film?coated tablets. Manufactured by Lilly del Caribe, Inc. and approved for import in China (NMPA No. HJ20240116; code 86978403001613). Supplied with clear indication for research/investigational use only, not for human therapeutic use. $2.00 -
Letrozole Capsules (Qipuyi®) – 2.5?mg?wholesale Price comparison
Letrozole is a potent nonsteroidal aromatase inhibitor, produced by Qilu Pharmaceutical Co., Ltd. (Qipuyi® brand). Each box contains 30 capsules (2.5?mg each), packaged as 3 blister cards. It’s approved in China under NMPA No.?H20213680, code 86981659000019, with barcodes 6915798005257 and 6915798005721. Strictly for laboratory research use—not for clinical or human applications. $1.00
评价
目前还没有评价